COMMUNIQUÉS West-GlobeNewswire

-
Cellectar Biosciences Announces Closing of $16.56 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
31/07/2018 - 22:05 -
Prothena to Report Second Quarter 2018 Financial Results on August 7
31/07/2018 - 22:05 -
Myriad Announces Closing of Counsyl Acquisition
31/07/2018 - 22:05 -
OmniSeq, Inc. to Participate in the NCI-MATCH Clinical Trial
31/07/2018 - 22:05 -
Zafgen to Host Conference Call to Discuss Second Quarter 2018 Financial Results
31/07/2018 - 22:05 -
Todos Medical, Ltd. Appoints Herman Weiss, MD MBA as New Chief Executive Officer
31/07/2018 - 22:03 -
Nuvectra™ to Report Second Quarter 2018 Financial Results on August 7, 2018
31/07/2018 - 22:01 -
Vital Therapies Announces Upcoming Second Quarter Financial Results Conference Call With Webcast
31/07/2018 - 22:01 -
Acer Therapeutics Announces Underwritten Public Offering
31/07/2018 - 22:01 -
NewLink Genetics Announces Clinical Plan, Reports Second Quarter 2018 Financial Results and Revises Cash Guidance
31/07/2018 - 22:01 -
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
31/07/2018 - 22:00 -
Medtronic Announces 2018 Global Champions Team
31/07/2018 - 20:01 -
Online Availability of Sanofi Group's Half-Year Financial Report for 2018
31/07/2018 - 18:16 -
Sanofi : Mise en ligne du rapport financier semestriel 2018
31/07/2018 - 18:16 -
Sanofi: Disclosure of trading in own shares
31/07/2018 - 18:01 -
Sanofi : Déclaration des transactions sur actions propres
31/07/2018 - 18:01 -
European Medicines Agency Confirms Accelerated Assessment Procedure for Trogarzo™
31/07/2018 - 17:18 -
L’Agence européenne des médicaments confirme la procédure d’évaluation accélérée pour Trogarzo(MC)
31/07/2018 - 17:18 -
HealthLynked Corp. Announces Participation in the 2018 Florida Medical Association Conference and Exhibition
31/07/2018 - 17:07
Pages